TITLE

Novel duplication on chromosome 16 (q12.1-q21) associated with behavioral disorder, mild cognitive impairment, speech delay, and dysmorphic features: case report

AUTHOR(S)
Odak, Ljubica; Barišic, Ingeborg; Pohovski, Leona Morožin; Riegel, Mariluce; Albert6Schinzel
PUB. DATE
June 2011
SOURCE
Croatian Medical Journal;Jun2011, Vol. 52 Issue 3, p415
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
We report on the 10-year follow-up and clinical, cytogenetic, and molecular investigation of a girl admitted for evaluation because of speech delay, learning difficulties, aggressive behavior, and dysmorphic facial features that included high forehead, round face, epicanthic folds, lowset dysplastic ears, flat nasal bridge, long flat philtrum, thin upper lip, small mouth, and short neck. The analysis of high-resolution GTG- and CTG-banding chromosomes suggested a de novo direct duplication of 16q12-q21 region and fluorescence in situ hybridization analysis with whole-chromosome specific 16 probe confirmed that the duplicated genetic material originated from the chromosome 16. Subsequently, array-based comparative genomic hybridization analysis with a ≈ 75 kb resolution showed a 9.92 Mb gain on the long arm of chromosome 16 at bands q12.1 through q21. To the best of our knowledge, this is the first case of duplication 16q12.1q21 described in literature. Several genes within the duplicated region are possibly correlated with clinical features present in our patient. Clinical and cytogenetic findings were compared with the small number of reported patients with pure duplications 16q, partially overlapping the one in our patient. Clinical phenotype seems to be distinctive between the proximalintermediate and intermediate-distal regions of the long arm of the chromosome 16. In particular, we observed a set of dysmorphic features that could present a characteristic dup 16q11.2-q13 phenotype. The present study illustrates the advantages of an integrative approach using both conventional and molecular techniques for the precise characterization and genotype-phenotype correlation in patients with dysmorphism, behavioral problems, and learning difficulties.
ACCESSION #
63192665

 

Related Articles

  • Sharing GJB2 / GJB6 Genetic Test Information with Family Members. Ariadna Martinez; Wayne Grody; Lisa Schimmenti // Journal of Genetic Counseling;Jun2007, Vol. 16 Issue 3, p313 

    Although GJB2/GJB6 genetic testing for non-syndromic hearing loss is available, there is no information regarding sharing of test results with family members. A qualitative study was conducted to elucidate if, how, and why parents of a child with hearing loss share GJB2/GJB6 test results with...

  • From the editors.  // Nature Reviews Genetics;Oct2011, Vol. 12 Issue 10, p665 

    An introduction is presented in which the editors discuss various reports within the issue on topics including the relationship between phenotype and genotype, the contributions of silent and non-synonymous mutations on diseases, and a discussion regarding direct-to-consumer genetic testing.

  • A Systematic Screen for Dominant Second-Site Modifiers of Merlin/NF2 Phenotypes Reveals an... LaJeunesse, Dennis R.; McCartney, Brooke M.; Fehon, Richard G. // Genetics;Jun2001, Vol. 158 Issue 2, p667 

    Presents a systematic screen designed to isolate dominant second-site modifiers of Drosophila homologue of human tumor suppressor gene Neurofibromatosis phenotypes. Multiallelic complementation groups that modify loss-of-function and dominant-negative Merlin phenotypes; Disruption of Merlin...

  • Screening Blood Donors for Hereditary Hemochromatosis: Decision Analysis Model Comparing Genotyping to Phenotyping. Adams, Paul C.; Valberg, Leslie S. // American Journal of Gastroenterology;Jun1999, Vol. 94 Issue 6, p1593 

    OBJECTIVE: The identification of a gene for hereditary hemochromatosis in 69-100% of typical hemochromatosis patients has resulted in a genotypic test to identify persons with the typical missense mutation. Population screening by genotyping has the potential to reduce screening costs because of...

  • Extensive clinical, hormonal and genetic screening in a large consecutive series of 46,XY neonates and infants with atypical sexual development. Baetens, Dorien; Mladenov, Wilhelm; Delle Chiaie, Barbara; Menten, Björn; Desloovere, An; Iotova, Violeta; Callewaert, Bert; Van Laecke, Erik; Hoebeke, Piet; De Baere, Elfride; Cools, Martine // Orphanet Journal of Rare Diseases;2014, Vol. 9 Issue 1, p416 

    Background One in 4500 children is born with ambiguous genitalia, milder phenotypes occur in one in 300 newborns. Conventional time-consuming hormonal and genetic work-up provides a genetic diagnosis in around 20-40% of 46,XY cases with ambiguous genitalia. All others remain without a definitive...

  • Large genomic fibrillin-1 ( FBN1) gene deletions provide evidence for true haploinsufficiency in Marfan syndrome. Mátyás, Gábor; Alonso, Sira; Patrignani, Andrea; Marti, Myriam; Arnold, Eliane; Magyar, István; Henggeler, Caroline; Carrel, Thierry; Steinmann, Beat; Berger, Wolfgang // Human Genetics;Aug2007, Vol. 122 Issue 1, p23 

    Mutations in the FBN1 gene are the major cause of Marfan syndrome (MFS), an autosomal dominant connective tissue disorder, which displays variable manifestations in the cardiovascular, ocular, and skeletal systems. Current molecular genetic testing of FBN1 may miss mutations in the promoter...

  • Genetic screening for iron overload: No evidence of discrimination at 1 year. Hall, Mark A.; Barton, James C.; Adams, Paul C.; McLaren, Christine E.; Reiss, Jacob A.; Castro, Oswaldo; Ruggiero, Andrea; Acton, Ronald T.; Power, Tara E.; Bent, Thomas C. // Journal of Family Practice;Oct2007, Vol. 56 Issue 10, p829 

    The article presents a study which assesses the extent of insurance and employment problems associated with population screening involving 101,168 primary care patients from the U.S. and Canada for iron phenotypes and hemochromatosis gene (HFE) genotypes associates with hemochromatosis. A...

  • Sensorineural Hearing Impairment in Children With Chiari I Malformation. Simons, Jeffrey P.; Ruscetta, Melissa N.; Chi, David H. // Annals of Otology, Rhinology & Laryngology;Jun2008, Vol. 117 Issue 6, p443 

    Objectives: We describe the prevalance of Chiari I malformation in children presenting to a pediatric tertiary care hearing loss clinic, characterize the phenotype of hearing loss in children with Chiari I malformation, and discuss the potential pathophysiology of sensorineural hearing...

  • Pachyonychia congenita type 2, N92S mutation of keratin 17 gene: clinical features, mutation analysis and pathological view. Cogulu, Ozgur; Onay, Huseyin; Aykut, Ayca; Wilson, Neil J.; Smith, Frances J. D.; Dereli, Tugrul; Ozkinay, Ferda // European Journal of Pediatrics;Oct2009, Vol. 168 Issue 10, p1269 

    Pachyonychia congenita (PC) type 2 is a rare inherited genetic disease characterized by hypertrophic nail dystrophy, palmoplantar hyperkeratosis and multiple pilosebaceous cysts. In some cases, natal teeth and hair abnormalities may be present. It is caused by mutations in keratin 17 or its...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics